|
(P1760) |
Transfemoral Implantation of the Edwards SAPIEN 3 Aortic Valve without Predilation is Safe and Feasible in the Majority of Patients |
| |
|
K. Bijuklic, J. Witt, K. Krause, L. Hansen, F.-C. Rieß, J. Schofer (Hamburg) |
|
(P1761) |
Diameters of Edwards Sapien XT transcatheter valves in relation to the filling volume of the implantation balloon |
| |
|
J. Müller-Ehmsen, M. Halbach, N. Bargiel, T. K. Rudolph, N. Madershahian, M. Scherner, T. Wahlers, S. Baldus (Hamburg, Köln) |
|
(P1762) |
Prosthesis-specific predictors of aortic regurgitation after transcatheter aortic valve implantation: An analysis from the randomized CHOICE trial |
| |
|
M. Abdel-Wahab, M. El-Mawardy, J. Mehilli, C. Frerker, F.-J. Neumann, T. Kurz, R. Tölg, G. Richardt (Bad Segeberg, München, Hamburg, Bad Krozingen, Lübeck) |
|
(P1763) |
Choice of a self-expandable valve in TAVI patients without calcification of left-ventricular outflow tract does not improve aortic regurgitation |
| |
|
T. Kurz, S. Desch, D. Richardt, H.-H. Sievers, H. Thiele (Lübeck) |
|
(P1764) |
Outcomes in patients undergoing transfemoral transcutaneous aortic valve implantation (TAVI) comparing general anesthesia versus local anesthesia plus mild sedation |
| |
|
A. Tesdorpf, H. Francksen, S. Freitag-Wolf, R. Petzina, G. Lutter, J. Renner, N. Frey, D. Frank (Kiel) |
|
(P1765) |
TAVI in local anesthesia without general anesthesia or deep sedation, a single center comparison of 30-day clinical outcome between balloon-expandable and self-expandable valves. |
| |
|
W. Bocksch, A. Prinz, B. Großmann, M. Steeg, M. Droppa, T. Geisler, M. Gawaz, S. Fateh-Moghadam (Tübingen) |
|
(P1766) |
The introduction of the third generation balloon expandable transcatheter heart valve allows for less valve oversizing |
| |
|
B. Brück, M. Deichstetter, M. Lieber, W. Eichinger, E. Hoffmann, J. Rieber (München) |
|
(P1767) |
Pseudoaneurysms after transcatheter aortic valve implantation (TAVI) using the ProStar XL system-comparison between the CoreValve , the Edwards Sapien XT and the Edwards Sapien 3 Valve. |
| |
|
S. Fateh-Moghadam, R. Jorbenadze, A. Kilias, M. Droppa, P. Htun, M. Gawaz, W. Bocksch (Tübingen) |
|
(P1768) |
Impact of computed tomography aortic annulus measurements during systole and diastole on prosthesis choice in patients undergoing TAVI procedures |
| |
|
U. Fischer-Rasokat, W.-K. Kim, C. Liebetrau, S. Möllmann, J. Blumenstein, L. Gaede, H. M. Nef, T. Walther, C. W. Hamm, H. Möllmann (Bad Nauheim, Gießen) |
|
(P1769) |
Frequency of ventricular pacing in patients receiving a permanent pacemaker after transcatheter aortic valve implantation |
| |
|
A. Rixe, Y. Seivani, S. de Waha, M. El-Mawardy, K. Gordian, G. Richardt, M. Abdel-Wahab (Bad Segeberg) |
|
(P1770) |
Changes of the eSheath Outer Dimensions used for Transfemoral Transcatheter Aortic Valve Replacement |
| |
|
T. Köhler, M. Büge, H. Schleiting, M. Seyfarth, K. Tiroch, M. M. Vorpahl (Wuppertal) |
|
(P1771) |
Single center experience of using a cerebral protection device in different TAVI valves – clinical follow up and histological analysis |
| |
|
T. Schmidt, U. Schäfer, O. D. Sanchez, E. Ladich, T. Thielsen, M. Schlüter, D. Schewel, J. Schewel, F. Kreidel, H. Alessandrini, K.-H. Kuck, C. Frerker (Hamburg; Maryland, US) |